Artelo Biosciences Risk Adjusted Performance
| ARTL Stock | | | USD 3.76 -0.14 -3.59% |
The Risk Adjusted Performance lookup presents technical context for Artelo Biosciences and related instruments. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. Artelo Biosciences has a market cap of 3.51 M, ROE of -4.36%.
Trending Equities can help frame allocation decisions. The allocation includes a position in Artelo Biosciences inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
Explore our
How to Trade Artelo Stock guide to learn how to trade Artelo Biosciences effectively.
Artelo Biosciences has current Risk Adjusted Performance of
-0.04.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | -0.04 | |
Artelo Biosciences Risk Adjusted Performance Peers Comparison
Artelo Risk Adjusted Performance Relative To Other Indicators
Artelo Biosciences carries a
third ranking for risk adjusted performance within its peer group. It is currently under evaluation for maximum drawdown within its peer group .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.